Vaxcyte, Inc.
PCVX
$54.03
$0.040.07%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 129.78M | 129.37M | 125.70M | 116.24M | 105.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.09B | 923.68M | 811.56M | 709.11M | 635.87M |
| Operating Income | -1.09B | -923.68M | -811.56M | -709.11M | -635.87M |
| Income Before Tax | -946.53M | -766.63M | -657.20M | -547.50M | -509.63M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -946.53 | -766.63 | -657.20 | -547.50 | -509.63 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -946.53M | -766.63M | -657.20M | -547.50M | -509.63M |
| EBIT | -1.09B | -923.68M | -811.56M | -709.11M | -635.87M |
| EBITDA | -1.07B | -907.28M | -799.80M | -698.62M | -626.91M |
| EPS Basic | -6.89 | -5.63 | -4.84 | -4.11 | -3.98 |
| Normalized Basic EPS | -4.31 | -3.52 | -3.02 | -2.57 | -2.49 |
| EPS Diluted | -6.89 | -5.63 | -4.84 | -4.11 | -3.98 |
| Normalized Diluted EPS | -4.31 | -3.52 | -3.02 | -2.57 | -2.49 |
| Average Basic Shares Outstanding | 548.17M | 544.35M | 543.12M | 530.62M | 511.84M |
| Average Diluted Shares Outstanding | 548.17M | 544.35M | 543.12M | 530.62M | 511.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |